Baxter InternationalWBO:BAX +4.49%56 FCF Margin % is 2.81% as of Mar. 2026, which is 72% below its 10-year median of 10.15. GuruFocus rates WBO:BAX with a GF Score™ of 56/100 and a GF Value™ of €28.97 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Baxter International ranks better than 65.28% on this metric.
The historical rank and industry rank for Baxter International's FCF Margin % or its related term are showing as below:
WBO:BAX'
s FCF Margin % Range Over the Past 10 Years
Min: 2.87 Med: 10.15 Max: 12.6
Current: 6.28
During the past 13 years, the highest FCF Margin % of Baxter International was 12.60%. The lowest was 2.87%. And the median was 10.15%.
WBO:BAX's FCF Margin % is ranked better than 65.28% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs WBO:BAX: 6.28
Baxter International FCF Margin % Related Terms
Baxter International FCF Margin % Historical Data
* Premium members only.
The historical data trend for Baxter International's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:BAX vs COO, ATR, RGEN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Baxter International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baxter International FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Baxter International's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baxter International (WBO:BAX) has a FCF Margin % of 2.81% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Baxter International and its competitors. This is 72% below median its historical median of 10.15. Over the past decade, Baxter International's FCF Margin % has ranged from 2.87 to 12.60. According to the industry distribution chart, Baxter International ranks #283 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 34.7%.
Is Baxter International's FCF Margin % too high?
Baxter International's current FCF Margin % of 2.81% is 72% below median its 10-year median of 10.15. Over the past 10 years, this metric has ranged from a low of 2.87 to a high of 12.60. Based on the distribution chart, Baxter International ranks #283 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Baxter International has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's FCF Margin % compare to COO and ATR?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #283 out of 815 companies for FCF Margin %. This puts Baxter International in the upper half of its industry. Historically, Baxter International's own FCF Margin % has ranged from 2.87 to 12.60 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Baxter International and its competitors. Baxter International's current FCF Margin % is 2.81%, which is 72% below median its own 10-year median of 10.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (WBO:BAX) is currently considered Possible Value Trap. The stock's GF Value™ is €28.97, compared to a current price of €18.38 — trading 36.6% below its estimated fair value. The current FCF Margin % is 2.81%, which is 72% below median its 10-year median of 10.15. Baxter International's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Baxter International (WBO:BAX), the current FCF Margin % is 2.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baxter International (WBO:BAX) Overvalued in 2026?
Based on GuruFocus' analysis, Baxter International stock appears to be undervalued.
The current stock price of €18.38 is trading 36.6% below its estimated GF Value™ of €28.97.
GuruFocus considers Baxter International to be Possible Value Trap.
Key valuation signals for WBO:BAX:
FCF Margin %: 2.81% (72% below median its 10-year median of 10.15)
GF Value™: €28.97 vs. price of €18.38 (36.6% below fair value)
No single metric tells the full story. See the WBO:BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
56GF Score
Get the complete analysis for WBO:BAX
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:BAX has been successfully added to your 
